5
Orphan Designations
0
FDA Approvals
7
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| congenital isolated hyperinsulinism | glucagon analog conjugated with human immunoglobulin G4 fragment | Orphan Designation | - |
| familial hyperinsulinism | glucagon analog conjugated with human immunoglobulin G4 fragment | Orphan Designation | - |
| hyperinsulinemic hypoglycemia, familial, 2 | glucagon analog conjugated with human immunoglobulin G4 fragment | Orphan Designation | - |
| idiopathic pulmonary fibrosis | glucagon-like peptide-1/glucagon/gastric inhibitory polypeptide triple agonist linked to human IgG4 Fc fragment | Orphan Designation | - |
| primary biliary cholangitis | Glucagon-like peptide-1/Glucagon/Gastric inhibitory polypeptide triple agonist linked to human IgG4 Fc fragment | Orphan Designation | - |
| primary sclerosing cholangitis | Glucagon-like peptide-1/Glucagon/Gastric inhibitory polypeptide triple agonist linked to human IgG4 Fc fragment | Orphan Designation | - |
| short bowel syndrome | human glucagon-like peptide-2 analogue linked to a human immunoglobulin Fc fragment (ready to use pre-filled syringe) | Orphan Designation | - |